These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
399 related articles for article (PubMed ID: 9613241)
21. Kinetics, biodistribution and therapeutic efficacy of hexylester 5-aminolevulinate induced photodynamic therapy in an orthotopic rat bladder tumor model. El Khatib S; Didelon J; Leroux A; Bezdetnaya L; Notter D; D'Hallewin M J Urol; 2004 Nov; 172(5 Pt 1):2013-7. PubMed ID: 15540780 [TBL] [Abstract][Full Text] [Related]
22. Expression levels of PEPT1 and ABCG2 play key roles in 5-aminolevulinic acid (ALA)-induced tumor-specific protoporphyrin IX (PpIX) accumulation in bladder cancer. Hagiya Y; Fukuhara H; Matsumoto K; Endo Y; Nakajima M; Tanaka T; Okura I; Kurabayashi A; Furihata M; Inoue K; Shuin T; Ogura S Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):288-95. PubMed ID: 23993855 [TBL] [Abstract][Full Text] [Related]
23. Optimization of differential photodynamic effectiveness between normal and tumor urothelial cells using 5-aminolevulinic acid-induced protoporphyrin IX as sensitizer. Seidl J; Rauch J; Krieg RC; Appel S; Baumgartner R; Knuechel R Int J Cancer; 2001 Jun; 92(5):671-7. PubMed ID: 11340570 [TBL] [Abstract][Full Text] [Related]
24. Photodynamic therapy for gastrointestinal tumors using three photosensitizers--ALA induced PPIX, Photofrin and MTHPC. A pilot study. Mĺkvy P; Messmann H; Regula J; Conio M; Pauer M; Millson CE; MacRobert AJ; Bown SG Neoplasma; 1998; 45(3):157-61. PubMed ID: 9717528 [TBL] [Abstract][Full Text] [Related]
25. Comparison of normal piglet bladder damage after PDT with oral or intravesical administration of ALA. Van Staveren HJ; Beek JF; Verlaan CW; Edixhoven A; De Reijke TM; Brutel De La RiviERe G; Star WM Lasers Med Sci; 2002; 17(4):238-45. PubMed ID: 12417977 [TBL] [Abstract][Full Text] [Related]
26. Photodynamic therapy of prostate cancer by means of 5-aminolevulinic acid-induced protoporphyrin IX - in vivo experiments on the dunning rat tumor model. Zaak D; Sroka R; Stocker S; Bise K; Lein M; Höppner M; Frimberger D; Schneede P; Reich O; Kriegmair M; Knüchel R; Baumgartner R; Hofstetter A Urol Int; 2004; 72(3):196-202. PubMed ID: 15084761 [TBL] [Abstract][Full Text] [Related]
27. Subcellular localization of Photofrin and aminolevulinic acid and photodynamic cross-resistance in vitro in radiation-induced fibrosarcoma cells sensitive or resistant to photofrin-mediated photodynamic therapy. Wilson BC; Olivo M; Singh G Photochem Photobiol; 1997 Jan; 65(1):166-76. PubMed ID: 9066298 [TBL] [Abstract][Full Text] [Related]
28. Regulation of 5-aminolevulinic acid-mediated protoporphyrin IX accumulation in human urothelial carcinomas. Inoue K; Karashima T; Kamada M; Shuin T; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J Pathobiology; 2009; 76(6):303-14. PubMed ID: 19955842 [TBL] [Abstract][Full Text] [Related]
29. Wavelength dependent photodynamic effects on chemically induced rat bladder tumors following intravesical instillation of 5-aminolevulinic acid. Stocker S; Knüchel R; Sroka R; Kriegmair M; Steinbach P; Baumgartner R J Urol; 1997 Jan; 157(1):357-61. PubMed ID: 8976297 [TBL] [Abstract][Full Text] [Related]
30. Optimisation of the formation and distribution of protoporphyrin IX in the urothelium: an in vitro approach. Marti A; Lange N; van den Bergh H; Sedmera D; Jichlinski P; Kucera P J Urol; 1999 Aug; 162(2):546-52. PubMed ID: 10411086 [TBL] [Abstract][Full Text] [Related]
31. Fluorescence diagnosis of bladder cancer: a novel in vivo approach using 5-aminolevulinic acid (ALA) dendrimers. François A; Battah S; MacRobert AJ; Bezdetnaya L; Guillemin F; D'Hallewin MA BJU Int; 2012 Dec; 110(11 Pt C):E1155-62. PubMed ID: 22883132 [TBL] [Abstract][Full Text] [Related]
32. Determination of the maximal tumor:normal bladder ratio after i.p. or bladder administration of 5-aminolevulinic acid in Fischer 344 rats by fluorescence spectroscopy in situ. Bisson JF; Christophe M; Padilla-Ybarra JJ; Notter D; Vigneron C; Guillemin F Anticancer Drugs; 2002 Sep; 13(8):851-7. PubMed ID: 12394271 [TBL] [Abstract][Full Text] [Related]
33. Biosynthesis and photodynamic efficacy of protoporphyrin IX (PpIX) generated by 5-aminolevulinic acid (ALA) or its hexylester (hALA) in rat bladder carcinoma cells. Cosserat-Gerardin I; Bezdetnaya L; Notter D; Vigneron C; Guillemin F J Photochem Photobiol B; 2000 Dec; 59(1-3):72-9. PubMed ID: 11332893 [TBL] [Abstract][Full Text] [Related]
34. Intravesical instillation of 5-aminolevulinic acid: the fluorescent metabolite is limited to urothelial cells. Steinbach P; Kriegmair M; Baumgartner R; Hofstädter F; Knüchel R Urology; 1994 Nov; 44(5):676-81. PubMed ID: 7974943 [TBL] [Abstract][Full Text] [Related]
35. Interstitial photodynamic therapy in subcutaneously implanted urologic tumors in rats after intravenous administration of 5-aminolevulinic acid. Xiao Z; Tamimi Y; Brown K; Tulip J; Moore R Urol Oncol; 2002; 7(3):125-32. PubMed ID: 12474546 [TBL] [Abstract][Full Text] [Related]
36. Microscopic quantification of hypercin fluorescence in an orthotopic rat bladder tumor model after intravesical instillation. Kamuhabwa AA; Roskams T; Baert L; De Witte PA Int J Oncol; 2003 Apr; 22(4):933-7. PubMed ID: 12632090 [TBL] [Abstract][Full Text] [Related]
37. Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers. Lilge L; Wilson BC J Clin Laser Med Surg; 1998 Apr; 16(2):81-91. PubMed ID: 9663099 [TBL] [Abstract][Full Text] [Related]
38. Accumulation of protoporphyrin-IX in rat Leydig cells following induction by 5-aminolevulinic acid and tramadol. Wołuń-Cholewa M; Butowska W; Warchoł W Photomed Laser Surg; 2007 Dec; 25(6):526-9. PubMed ID: 18158756 [TBL] [Abstract][Full Text] [Related]
39. In vivo photoproduct formation during PDT with ALA-induced endogenous porphyrins. König K; Schneckenburger H; Rück A; Steiner R J Photochem Photobiol B; 1993 May; 18(2-3):287-90. PubMed ID: 8350194 [TBL] [Abstract][Full Text] [Related]
40. How to avoid local side effects of bladder photodynamic therapy: impact of the fluence rate. François A; Salvadori A; Bressenot A; Bezdetnaya L; Guillemin F; D'Hallewin MA J Urol; 2013 Aug; 190(2):731-6. PubMed ID: 23353049 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]